Last reviewed · How we verify

NCT03539835

Resistance Training to Improve Fatigue and Physical Function in Postmenopausal Breast Cancer Survivors

Completed NA Last updated 27 July 2020
What this trial tests

NA trial testing Resistance training (RT) in Cancer in 28 participants. Completed in 12 March 2020.

Timeline
10 December 2018
Primary endpoint
9 March 2020
12 March 2020

Quick facts

Lead sponsorEmory University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment28
Start date10 December 2018
Primary completion9 March 2020
Estimated completion12 March 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Emory University

Who can join

Adults 50 to 75, female only, with Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will begin to fill a knowledge gap by determine whether changes in kynurenine metabolism occur following Resistance Training (RT) and relate to reductions in inflammation and improved behavioral and physical function as this may identify potential targets for interventions to promote cancer recovery.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The kynurenine pathway: a finger in every pie.
    Savitz J. · · 2020 · cited 542× · PMID 30980044 · DOI 10.1038/s41380-019-0414-4

Verify or expand the search:

Other trials of Resistance training (RT)

Trials testing the same drug.

Other recruiting trials for Cancer

Currently open trials in the same condition.

Other Emory University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03539835.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing